Publikationen (18) Publikationen, an denen Forscher/innen teilgenommen haben

2020

  1. Clinical applications of molecular biomarkers in prostate cancer

    Cancers, Vol. 12, Núm. 6, pp. 1-25

  2. Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer

    BMC Cancer, Vol. 20, Núm. 1

  3. HDR Prostate Brachytherapy

    Seminars in Radiation Oncology, Vol. 30, Núm. 1, pp. 49-60

  4. High-dose-rate brachytherapy for localized penile cancer: Evolution of a technique

    Brachytherapy, Vol. 19, Núm. 2, pp. 201-209

  5. Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter study

    Clinical and Translational Oncology, Vol. 22, Núm. 9, pp. 1635-1644

  6. MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?

    Clinical and Translational Radiation Oncology, Vol. 24, pp. 135-139

  7. Manejo de malformaciones arteriovenosas cerebrales

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 117, Núm. 1, pp. 38-42

  8. Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital

    Scientific Reports, Vol. 10, Núm. 1

  9. Microdosimetry-based determination of tumour control probability curves for treatments with 225Ac-PSMA of metastatic castration resistant prostate cancer

    Physics in Medicine and Biology, Vol. 65, Núm. 23

  10. OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): A randomized open label trial

    Radiation Oncology, Vol. 15, Núm. 1

  11. Oligometastatic prostate adenocarcinoma. Clinical-pathologic study of a histologically under-recognized prostate cancer

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-9

  12. PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): A study protocol for a randomized controlled phase II trial

    BMC Cancer, Vol. 20, Núm. 1

  13. Pain response and quality of life assessment in patients with moderate/severe neuropathic pain due to bone metastasis undergoing treatment with palliative radiotherapy and tapentadol: A prospective multicentre pilot study

    Journal of Medical Imaging and Radiation Oncology, Vol. 64, Núm. 6, pp. 859-865

  14. Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial

    Radiotherapy and Oncology, Vol. 146, pp. 16-20

  15. Precision Radiation Therapy for Metastatic Spinal Cord Compression: Final Results of the PRE-MODE Trial

    International Journal of Radiation Oncology Biology Physics, Vol. 106, Núm. 4, pp. 780-789

  16. Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis

    Trials, Vol. 21, Núm. 1

  17. Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group

    European urology oncology, Vol. 3, Núm. 4, pp. 455-463

  18. Systematic review of educational interventions to improve contouring in radiotherapy

    Radiotherapy and Oncology, Vol. 144, pp. 86-92